APXT
Apex Treasury Corporation Class A
There isn't enough reported data to score APXT yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
APXT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
APXT's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like APXT.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
APXT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 50x | $10.21 | — |
| Cheap | 85x | $16.96 | +66% |
| Fair | 86x | $17.10 | +68% |
| Expensive | 108x | $21.52 | +111% |
Historical ranges are pointers, not guarantees.
APXT's PE is 50x, but its earnings don't support one, so it isn't a reliable read right now.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
APXT Forward outlook
There aren't enough analyst estimates for APXT to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
APXT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.20 | +$1.34 |
| Q2 2026 | $0.16 | +$1.29 |
| Q1 2026 | $0.12 | +$1.32 |
APXT has the edge over IREN in the latest year-over-year earnings comparison.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
APXT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $114.7M | -60% |
APXT's revenue has slid since its 2024 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 13% | +5.5 points |
| Q1 2025 | 3.5% | +28 points |
| Q4 2024 | 7.2% | N/A |
| Q3 2024 | 8.6% | N/A |
| Q2 2024 | -2.7% | N/A |
| Q2 2021 | -24% | N/A |
APXT's operating margin was 13% last quarter, up 15 points from the same quarter a year ago.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over APXT in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
APXT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$211.7K | -$211.7K |
| Q2 2026 | -$23.4M | -228% |
| Q1 2026 | $23M | +$24M |
| Q4 2025 | $29M | -66% |
| Q3 2025 | $0 | -100% |
| Q2 2021 | -$243 | +$210.3K |
| Q1 2021 | -$358.1K | +$24.8K |
| Q2 2020 | -$210.5K | -$210.5K |
APXT has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
APXT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +33% | +11.5M shares |
| 1 year | +360% | +36M shares |
| 3 years | +3.1% | +1.4M shares |
APXT has 46M diluted shares, up 360% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $59.8M |
| Q1 2026 | $59.8M |
| Q4 2025 | — |
| Q2 2025 | $19M |
| Q1 2025 | $11.9M |
| Q4 2024 | $33.1M |
| Q3 2024 | $21.7M |
| Q2 2021 | — |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over APXT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
APXT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -40.5x | Net Cash |
| Q1 2025 | -41.4x | Net Cash |
APXT has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like APXT.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
APXT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 75.7 | Overbought |
| Stochastic | 80.0 | Overbought |
APXT's weekly RSI is 76 (overbought) and its Stochastic is 80 (overbought).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
APXT PE vs Financial Services Sector
| Metric | APXT | Sector median | Relative |
|---|---|---|---|
| PE | 50x | 13x | 287% above |
| PE % | 0 | 12 | 12 pts below |
APXT is trading at 50x earnings, a 287% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
APXT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.2 | 0.5% above |
| 20 week MA | $10.1 | 0.8% above |
| 50 week MA | $10.0 | 1.8% above |
APXT has stronger trend alignment. APXT is above 3 of 3 weekly averages versus IREN above 1 of 5.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
APXT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $9.89 | $9.88 | -0.1% |
| 2026 YTD | $9.88 | $10.2 | +3.3% |
APXT has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.